BioSpace News Archive

Business

BioBright, Sanger Institute Aim to Cut Drug-Development Time

BioBright, a firm dedicated to creating the smart laboratory of the future, has announced a collaboration with the Wellcome Sanger Institute that could lead to the faster development of drugs for diseases of the immune system like rheumatoid arthritis.

January 22, 2018
·
3 min read
Business

Ligand Enters into Worldwide OmniAb Platform License Agreement with Ferring Pharmaceuticals

Under the license, Ferring will be able to use the full OmniAb platform including OmniRat®, OmniMouse®, OmniFlic® and OmniChicken™ to discover fully human mono- and bispecific antibodies.

January 22, 2018
·
5 min read
Enzo Biochem Announces New Validated Cost-Effective Cervical Cancer Biomarker Detection Test

Enzo Biochem (NYSE:ENZ), an integrated diagnostics company, announced today validation of a cervical cancer biomarker detection test that provides a highly robust and cost-efficient solution for anatomical pathology.

January 22, 2018
·
4 min read
Drug Development

AIT Therapeutics Announces Further Data From Its NO-NTM Abscessus Phase II Clinical Trial in Nontuberculous Mycobacteria (NTM) Patients

The Company previously announced positive preliminary data through Day 51.

January 22, 2018
·
6 min read
PositiveID Corporation Announces Lawrence Livermore National Laboratory Evaluation of PositiveID’s FireflyDX

PositiveID and ExcitePCR have published the report on their websites.

January 22, 2018
·
5 min read
Drug Development

Agenus Announces Combination Clinical Trials of its Anti-CTLA4 (AGEN1884) & Anti-PD1 (AGEN2034)

This Phase 1/2 clinical trial launched in December 2017 and enrollment into the first cohort has been rapidly completed.

January 22, 2018
·
3 min read
Business

Symic Bio Appoints Hicham Alaoui, Ph.D., as Senior VP of Discovery Biology

With this appointment, Dr. Alaoui will lead research into the identification and characterization of novel therapeutics enabled by the Symic Bio platform.

January 22, 2018
·
2 min read
Drug Development

Pulmatrix Announces Acceptance of a Clinical Trial Application in Europe for Pulmazole - an Inhaled Dry-Powder iSPERSE Formulation of Itraconazole

This phase 1/1b study will be conducted in healthy subjects and patients with mild to moderate stable asthma.

January 22, 2018
·
5 min read
Cynata Therapeutics: Encouraging Early Safety and Efficacy Data in Cynata’s Phase I Trial of CYP-001 in GvHD; DSMB Recommendation to Initiate Enrollment of Second Patient Cohort

The DSMB has recommended that Cynata’s clinical trial of its lead Cymerus product CYP-001 should progress to the next stage as planned.

January 22, 2018
·
6 min read
BioMidwest

Myriad Applauds New Consensus Statement From International Expert Panel On Screening Recommendations for Hereditary Prostate Cancer

The consensus recommendations point to the need for routine obtainment of family history information and hereditary cancer counselling for men with prostate cancer seen by either a urologist or oncologist.

January 22, 2018
·
6 min read